297 related articles for article (PubMed ID: 25368217)
21. [Too positive comment on glitazones].
Lindberg M
Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
[No Abstract] [Full Text] [Related]
22. [Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence].
Heine RJ
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):930-1; author reply 932-3. PubMed ID: 16686095
[No Abstract] [Full Text] [Related]
23. American Diabetes Association meeting (25-29 June 2010, Orlando, Florida).
Mayor S
Prim Care Diabetes; 2011 Apr; 5(1):63-4. PubMed ID: 20728419
[No Abstract] [Full Text] [Related]
24. From the World Congress of Cardiology, Barcelona, 2006--Support for wider metformin usage in type 2 diabetes.
Cardiovasc J S Afr; 2006; 17(5):267. PubMed ID: 17117236
[No Abstract] [Full Text] [Related]
25. [The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].
Szymborska-Kajanek A; Strojek K
Kardiol Pol; 2006 Mar; 64(3):322-5; discussion 325-6. PubMed ID: 16583340
[No Abstract] [Full Text] [Related]
26. From hyperglycemia to the risk of cardiovascular disease.
Leiter LA
Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
[TBL] [Abstract][Full Text] [Related]
27. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
28. Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
Chen J; Raymond K
Vasc Health Risk Manag; 2008; 4(6):1265-72. PubMed ID: 19337540
[TBL] [Abstract][Full Text] [Related]
29. How important is diabetes as a risk factor for cardiovascular and other diseases in older adults?
Kengne AP; Patel A
PLoS Med; 2006 Oct; 3(10):e424. PubMed ID: 17048981
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of some antidiabetic drugs.
Med Lett Drugs Ther; 2017 Aug; 59(1527):136-138. PubMed ID: 28787745
[No Abstract] [Full Text] [Related]
31. Metformin: a multitasking medication.
Bailey CJ
Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
[No Abstract] [Full Text] [Related]
32. [Is it necessary to systematically treat diabetics with statins?].
Vergès B
Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
[No Abstract] [Full Text] [Related]
33. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
Kwan BC; Beddhu S; Kronenberg F; Cheung AK
Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
[No Abstract] [Full Text] [Related]
34. AACE comprehensive diabetes management algorithm 2013.
Garber AJ; Abrahamson MJ; Barzilay JI; Blonde L; Bloomgarden ZT; Bush MA; Dagogo-Jack S; Davidson MB; Einhorn D; Garvey WT; Grunberger G; Handelsman Y; Hirsch IB; Jellinger PS; McGill JB; Mechanick JI; Rosenblit PD; Umpierrez G; Davidson MH;
Endocr Pract; 2013; 19(2):327-36. PubMed ID: 23598536
[No Abstract] [Full Text] [Related]
35. [New drugs for type 2 diabetes: expanding cardiovascular protection beyond type 2 diabetes?].
Mannucci E
G Ital Cardiol (Rome); 2012 Dec; 13(12 Suppl 1):3S. PubMed ID: 23258122
[No Abstract] [Full Text] [Related]
36. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
Bajaj M; Jialal I
Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
[No Abstract] [Full Text] [Related]
37. [Early insulin therapy reduces cardiovascular risk].
Med Monatsschr Pharm; 2007 Apr; 30(4):160-1. PubMed ID: 17484451
[No Abstract] [Full Text] [Related]
38. Anticipatory care for the diabetic-hypertensive bundle.
Hart JT
Prim Care Diabetes; 2008 Dec; 2(4):165-6. PubMed ID: 19008169
[No Abstract] [Full Text] [Related]
39. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.
Meerwaldt R; Links T; Zeebregts C; Tio R; Hillebrands JL; Smit A
Cardiovasc Diabetol; 2008 Oct; 7():29. PubMed ID: 18840258
[TBL] [Abstract][Full Text] [Related]
40. [Empagliflozin: an oral antidiabetic with documented positive effect on cardiac mortality].
Zechmann S
Praxis (Bern 1994); 2016 Mar; 105(6):349-50. PubMed ID: 26980688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
